Alector, Inc

(NASDAQ:ALEC)

Latest On Alector, Inc (ALEC):

Date/Time Type Description Signal Details
2023-05-04 22:00 ESTNewsAlector GAAP EPS of -$0.55, revenue of $16.5MN/A
2023-03-01 07:09 ESTNewsAlector GAAP EPS of -$0.63 misses by $0.09, revenue of $14.44M misses by $11.44MN/A
2023-02-03 18:01 ESTNewsAlector: Trading At Cash Despite Late Stage CNS PipelineN/A
2022-11-10 12:40 ESTNewsAlector hits 52-week low after Q3 results as analysts focus on pipelineN/A
2022-11-09 19:54 ESTNewsAlector hits 52-week after Q3 results as analysts focus on pipelineN/A
2022-11-09 01:55 ESTNewsAlector GAAP EPS of -$0.56 misses by $0.09, revenue of $14.85M misses by $16.54MN/A
2022-11-04 15:26 ESTNewsAlector: Lots Of Long Term Potential, Lots Of CashN/A
2022-10-04 12:50 ESTNewsAlector: Advancement Of Third Alzheimer's Drug Brings About Huge PotentialN/A
2022-09-09 17:52 ESTNewsAlector stock falls 12% as Morgan Stanley cuts rating on long path for AL001N/A
2022-08-04 23:03 ESTNewsAlector GAAP EPS of $0.12 beats by $0.60, revenue of $79.85M beats by $49.81MN/A
2022-07-08 14:52 ESTNewsAbbVie ends partnership with Alector for Alzheimer’s candidateN/A
2022-06-15 04:50 ESTNewsAlector: Potential In Neurology And Cancer TreatmentsN/A
2022-05-05 20:55 ESTNewsAlector GAAP EPS of -$0.54 misses by $1.22, revenue of $24.5MN/A
2022-04-16 14:49 ESTNewsAlector: Expect Phase 3 Data Next YearN/A
2022-03-29 21:35 ESTNewsAlector names new medical chiefN/A
2022-03-24 03:11 ESTNewsAlector (ALEC) Presents Twelve Month ResultsN/A
2022-03-09 02:51 ESTNewsAlector downgraded at Stifel on prospects for late-stage dementia candidateN/A
2022-02-25 04:06 ESTNewsAlector GAAP EPS of -$0.68 misses by $0.75, revenue of $14M misses by $69.82MN/A
2022-02-07 17:25 ESTNewsAlector appoints new finance chiefN/A
2022-01-26 17:22 ESTNewsAlector, Inc: A Newer Biotech Company With Big PotentialN/A
2021-11-05 00:41 ESTNewsAlector EPS misses by $1.49, misses on revenueN/A
2021-10-30 07:25 ESTNewsAlector: The GSK Deal Is A Major Value AddN/A
2021-09-21 11:39 ESTNewsAlector EPS misses by $0.01, misses on revenueN/A
2021-09-09 19:55 ESTNewsDosing underway in Alector's Phase 2 AL001 study in amyotrophic lateral sclerosisN/A
2021-09-08 23:42 ESTNewsAlector slides as two top executives plan to leaveN/A
2021-07-29 13:32 ESTNewsAlector phase 2 data on AL001 shows benefit in frontotemporal dementia (updated)N/A
2021-07-25 00:07 ESTNewsAAIC 2021: What to look for at Alzheimer's biggest annual conferenceN/A
2021-07-20 18:34 ESTNewsCentogene, Alector initiate EFRONT study in frontotemporal dementiaN/A
2021-07-20 18:31 ESTNewsMerus upgraded on ASCO update, Cantor favors Harpoon after selloff; and more in today’s analyst actionN/A
2021-07-20 18:19 ESTNewsAlector surges on deal with GSK for experimental drugs targeting neurological diseasesN/A
2021-07-20 18:12 ESTNewsAlector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rallyN/A
2021-05-06 06:55 ESTNewsAlector EPS in-line, misses on revenueN/A
2021-03-19 11:29 ESTNewsAlector up 18% after patent application published for Alzheimer's programN/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.13 to $31.88.Neutral
2021-03-01 11:04 ESTEarnings EstimateAn EPS average of -$2.84 is estimated for the 2022 year.Sell
2021-03-01 11:04 ESTEarnings EstimateAn EPS average of -$0.72 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-26 15:03 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 18:56 ESTNewsAlector EPS misses by $0.02, misses on revenueN/A
2021-01-25 12:50 ESTNewsDoing underway in Alector, AbbVie's study of AL002 in Alzheimer’s diseaseN/A
2021-01-21 05:34 ESTNewsAlector's business chief steps downN/A
2021-01-18 07:04 ESTAnalyst RatingThe Analyst Target Price has increased from $31.71 to $32.13.Buy
2021-01-15 07:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.88 to $31.71.Neutral
2021-01-07 22:34 ESTNewsAlector gives update on its frontotemporal dementia and Alzheimer’s disease trialsN/A
2020-12-28 20:51 ESTNewsAlector: Activating Microglia To Treat NeurodegenerationN/A
2020-12-24 15:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $33.63 to $31.88.Neutral
2020-12-13 03:08 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:06 ESTFinancialsCompany financials have been released.Neutral
2020-12-07 21:17 ESTNewsAlector: AL001's Phase 3 Initiation/Phase 2 Readout In 2021, $462M In Cash, And AbbVie's Promising Support, +38% UpsideN/A
2020-11-25 11:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $34.75 to $33.63.Neutral

About Alector, Inc (ALEC):

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.

See Advanced Chart

General

  • Name Alector, Inc
  • Symbol ALEC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 171
  • Fiscal Year EndDecember
  • IPO Date2019-02-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.alector.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 68.96
  • Price/Book (Most Recent Quarter) 5.57
  • Enterprise Value Revenue 53.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.90
  • Next Year EPS Estimate -$2.61
  • Next Quarter EPS Estimate -$0.69
  • Operating Margin -924%
  • Return on Assets -27%
  • Return on Equity -82%
  • Revenue 21.1 million
  • Earnings Per Share -$2.26
  • Revenue Per Share $0.27
  • Gross Profit -135771000
  • Quarterly Earnings Growth -19.1%
View More

Highlights

  • Market Capitalization 1.43 billion
  • EBITDA -80913000
  • PE Ratio -3.76
  • Analyst Target Price $31.88
  • Book Value Per Share $3.37
View More

Share Statistics

  • Shares Outstanding 79.58 million
  • Shares Float 56.59 million
  • % Held by Insiders 1281%
  • % Held by Institutions 78.94%
  • Shares Short 5.41 million
  • Shares Short Prior Month 5.05 million
  • Short Ratio 9.62
  • Short % of Float 12%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.04
  • 52 Week High $34.89
  • 52 Week Low $9.12
  • 50 Day Moving Average 18.61
  • 200 Day Moving Average 14.44
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Alector, Inc (ALEC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Alector, Inc (ALEC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$4.85 million-$0.66-$0.65-1.93%
2020-09-302020-11-10$N/A-$0.67-$0.55-22.53%
2020-06-302020-08-11$N/A-$0.58-$0.50-14.99%
2020-03-312020-05-13$7.17 million-$0.53-$0.43-22.69%
2019-12-312020-03-24$6 million-$0.45-$0.44-1.69%
2019-09-302019-11-12$2.7 million-$0.47-$0.40-17.5%
2019-06-302019-08-12$6.92 million-$0.36-$0.32-12.5%
2019-03-312019-05-13$5.61 million-$0.27-$0.3214.29%
2018-12-312019-03-26$9.15 million-$0.27-$0.27-0.37%

Alector, Inc (ALEC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 44.38 million N/A N/A 34.61 million N/A
Income Before Tax -52.18 million N/A N/A -40.02 million N/A
Selling General Administrative 13.23 million N/A N/A 14.64 million 12.58 million
Gross Profit 4.85 million N/A N/A N/A N/A
Ebit -52.18 million N/A N/A -40.34 million N/A
Operating Income -52.76 million N/A N/A -42.08 million N/A
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 4.85 million N/A N/A 7.17 million 6 million
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A 2.06 million N/A
Net Income From Continuing Operations -52.18 million N/A N/A -40.02 million N/A
Net Income Applicable to Common Shares -52.18 million -52.7 million -45.33 million N/A N/A
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -124.87 million N/A 48.21 million
Change to Liabilities -9.25 million -1.87 million N/A N/A -2.98 million
Total Cash Flow from Investing Activities 33.01 million -24.74 million N/A N/A 45.91 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 228.46 million 172.35 million 720000
Change to Operating Activities 10.81 million -7.45 million N/A N/A 1.64 million
Change in Cash N/A N/A 71.28 million 24.17 million 17.77 million
Total Cash from Operating Activities -40.82 million -45.94 million -32.31 million N/A -28.86 million
Depreciation N/A N/A 1.74 million 3.78 million 1.28 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 8.53 million 6.94 million N/A N/A 2.93 million
Capital Expenditures N/A N/A 3.57 million N/A 2.3 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 220.72 million N/A N/A 227.19 million 227.17 million
Total Stockholder Equity 267.53 million N/A N/A 391.73 million 194.74 million
Other Current Liabilities 42.55 million 26.6 million N/A N/A N/A
Total Assets 488.25 million N/A N/A 618.93 million 421.91 million
Common Stock 8000 8000 8000 N/A 7000
Other Current Assets 8.2 million N/A N/A N/A N/A
Retained Earnings -410.05 million -357.87 million -305.17 million -259.84 million N/A
Other Liabilities N/A 111.05 million 110.81 million N/A N/A
Other Assets N/A 3.69 million 2.56 million N/A 2.15 million
Cash 49.97 million N/A N/A 160.92 million 89.64 million
Total Current Liabilities 68.09 million 71.09 million N/A 71.78 million 61.97 million
Other Stockholder Equity 614000 1.09 million 1.85 million N/A 142000
Property, Plant & Equipment 30.18 million 57.89 million 59.38 million N/A 62.33 million
Total Current Assets 421.51 million 470.01 million N/A 556.2 million 357.44 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 267.53 million 310.19 million 355.33 million N/A N/A
Short Term Investments 363.34 million N/A N/A 387.62 million N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 25.54 million 1.37 million N/A 4.04 million N/A

Alector, Inc (ALEC) Chart:

Alector, Inc (ALEC) News:

Below you will find a list of latest news for Alector, Inc (ALEC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Alector, Inc (ALEC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0745.14TRUE00
2024-05-1752.4CALL10 32119.91TRUE2.40
2024-05-177.50.35CALL1 61230.48FALSE0.350
2024-05-17100CALL0 00FALSE00
2024-05-1712.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.4PUT0 5193.72FALSE00
2024-05-177.52.5PUT0 1402.02TRUE00
2024-05-17100PUT0 0431.3TRUE00
2024-05-1712.50PUT0 0314.44TRUE00
2024-06-212.50CALL0 0258.22TRUE00
2024-06-2150CALL0 065.43TRUE00
2024-06-217.50.1CALL0 276.86FALSE00
2024-06-21100CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 064.14FALSE00
2024-06-217.50PUT0 0211.98TRUE00
2024-06-21100PUT0 0246.3TRUE00
2024-07-192.52.75CALL0 20176.86TRUE00
2024-07-1951.25CALL0 489.77TRUE00
2024-07-197.50.3CALL0 25482.52FALSE00
2024-07-19100.35CALL0 550FALSE00
2024-07-1912.50.23CALL0 300FALSE00
2024-07-19150.19CALL0 390FALSE00
2024-07-192.50.23PUT0 50FALSE00
2024-07-1950.55PUT0 2679.79FALSE00
2024-07-197.51.72PUT0 35156.29TRUE00
2024-07-19103.4PUT0 0211.66TRUE00
2024-07-1912.50PUT0 0224.37TRUE00
2024-07-19150PUT0 0246.93TRUE00
2024-10-182.50CALL0 0186.87TRUE00
2024-10-1852.35CALL0 781.82TRUE00
2024-10-187.50.65CALL0 1290.17FALSE00
2024-10-18100.3CALL0 136134.14FALSE00
2024-10-1812.50.45CALL0 200FALSE00
2024-10-182.50.23PUT0 1115.11FALSE00
2024-10-1850.88PUT0 187.07FALSE00
2024-10-187.52.45PUT0 3107.09TRUE00
2024-10-18100PUT0 080.49TRUE00
2024-10-1812.50PUT0 0140.18TRUE00
2025-01-172.50CALL0 0136.56TRUE00
2025-01-1752.85CALL0 2119.54TRUE00
2025-01-177.51.8CALL42 796141.23FALSE1.80
2025-01-17101CALL0 71130.9FALSE00
2025-01-1712.50.6CALL0 150128.6FALSE00
2025-01-17150CALL0 0122.91FALSE00
2025-01-172.50PUT0 0114.1FALSE00
2025-01-1751.75PUT0 37107.58FALSE00
2025-01-177.50PUT0 095.51TRUE00
2025-01-17103.8PUT0 5110.15TRUE00
2025-01-1712.50PUT0 0121.58TRUE00
2025-01-17150PUT0 0128.83TRUE00

Latest ALEC Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$7.83
Jun 13, 2022 7:59 PM EST56$7.83
Jun 13, 2022 7:59 PM EST52$7.83
Jun 13, 2022 7:59 PM EST80$7.83
Jun 13, 2022 7:59 PM EST11$7.83

Alector, Inc (ALEC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2018-11-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018034674/0000000000-18-034674-index.htm
2018-12-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018037148/0000000000-18-037148-index.htm
2018-12-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018038840/0000000000-18-038840-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2019-02-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000130/0000947871-19-000130-index.htm
2019-08-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000575/0000947871-19-000575-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000979/0000947871-19-000979-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-01-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000022/0000947871-20-000022-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2020-02-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000087/0000947871-20-000087-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-03-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000184/0000947871-20-000184-index.htm
2020-03-24144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000254/0000947871-20-000254-index.htm
2020-03-24144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000255/0000947871-20-000255-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-30144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000302/0000947871-20-000302-index.htm
2020-03-30144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000303/0000947871-20-000303-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2020-04-09144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000369/0000947871-20-000369-index.htm
2020-04-09144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000370/0000947871-20-000370-index.htm
2020-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000387/0000947871-20-000387-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000541/0000947871-20-000541-index.htm
2020-07-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000614/0000947871-20-000614-index.htm
2020-07-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000626/0000947871-20-000626-index.htm
2018-10-12DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318009894/0000950123-18-009894-index.htm
2018-10-12DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318009895/0000950123-18-009895-index.htm
2018-11-16DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012133/0000950123-18-012133-index.htm
2018-11-16DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012135/0000950123-18-012135-index.htm
2018-12-17DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012426/0000950123-18-012426-index.htm
2019-12-02DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012319011700/0000950123-19-011700-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000110465919008620/0001104659-19-008620-index.htm
2019-01-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519003772/0001193125-19-003772-index.htm
2019-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519003779/0001193125-19-003779-index.htm
2019-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519003784/0001193125-19-003784-index.htm
2019-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519019648/0001193125-19-019648-index.htm
2019-01-318-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1653087/000119312519024072/0001193125-19-024072-index.htm
2019-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519026990/0001193125-19-026990-index.htm
2019-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519026991/0001193125-19-026991-index.htm
2019-02-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519029514/0001193125-19-029514-index.htm
2019-02-06FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519029585/0001193125-19-029585-index.htm
2019-02-07424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1653087/000119312519030566/0001193125-19-030566-index.htm
2019-02-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519030597/0001193125-19-030597-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312519033930/0001193125-19-033930-index.htm
2019-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519088558/0001193125-19-088558-index.htm
2019-03-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1653087/000119312519088567/0001193125-19-088567-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312519172525/0001193125-19-172525-index.htm
2020-01-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312520015336/0001193125-20-015336-index.htm
2020-01-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312520015374/0001193125-20-015374-index.htm
2020-01-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312520015381/0001193125-20-015381-index.htm
2020-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312520017882/0001193125-20-017882-index.htm
2020-01-29S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520018822/0001193125-20-018822-index.htm
2020-01-30424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520019151/0001193125-20-019151-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520024249/0001193125-20-024249-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000119312520033331/0001193125-20-033331-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520067324/0001193125-20-067324-index.htm
2020-05-13S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1653087/000119312520141645/0001193125-20-141645-index.htm
2020-05-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520141685/0001193125-20-141685-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520141724/0001193125-20-141724-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520143955/0001193125-20-143955-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000119380519000158/0001193805-19-000158-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007883/0001209191-19-007883-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007884/0001209191-19-007884-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007885/0001209191-19-007885-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007886/0001209191-19-007886-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007887/0001209191-19-007887-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007889/0001209191-19-007889-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007890/0001209191-19-007890-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007892/0001209191-19-007892-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007894/0001209191-19-007894-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007896/0001209191-19-007896-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007898/0001209191-19-007898-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007925/0001209191-19-007925-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007926/0001209191-19-007926-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009113/0001209191-19-009113-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009114/0001209191-19-009114-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009119/0001209191-19-009119-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009780/0001209191-19-009780-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009784/0001209191-19-009784-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029727/0001209191-19-029727-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029732/0001209191-19-029732-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029734/0001209191-19-029734-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029736/0001209191-19-029736-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029740/0001209191-19-029740-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029743/0001209191-19-029743-index.htm
2019-08-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119045559/0001209191-19-045559-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119045564/0001209191-19-045564-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055820/0001209191-19-055820-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055823/0001209191-19-055823-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055826/0001209191-19-055826-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055827/0001209191-19-055827-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055829/0001209191-19-055829-index.htm
2019-11-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057197/0001209191-19-057197-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060223/0001209191-19-060223-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005031/0001209191-20-005031-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005056/0001209191-20-005056-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120021014/0001209191-20-021014-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120021016/0001209191-20-021016-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028986/0001209191-20-028986-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028991/0001209191-20-028991-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028993/0001209191-20-028993-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028995/0001209191-20-028995-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028997/0001209191-20-028997-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120029004/0001209191-20-029004-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053597/0001209191-20-053597-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053599/0001209191-20-053599-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053605/0001209191-20-053605-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053606/0001209191-20-053606-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053612/0001209191-20-053612-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053614/0001209191-20-053614-index.htm
2019-02-04CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1653087/000135445719000055/0001354457-19-000055-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019009355/0001564590-19-009355-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1653087/000156459019009358/0001564590-19-009358-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019018836/0001564590-19-018836-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019018837/0001564590-19-018837-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019019627/0001564590-19-019627-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019031472/0001564590-19-031472-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019031482/0001564590-19-031482-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019031488/0001564590-19-031488-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019042915/0001564590-19-042915-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019042920/0001564590-19-042920-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019045755/0001564590-19-045755-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019045969/0001564590-19-045969-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020012509/0001564590-20-012509-index.htm
2020-03-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1653087/000156459020012520/0001564590-20-012520-index.htm
2020-03-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1653087/000156459020012557/0001564590-20-012557-index.htm
2020-03-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1653087/000156459020014173/0001564590-20-014173-index.htm
2020-03-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1653087/000156459020014205/0001564590-20-014205-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020024870/0001564590-20-024870-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459020025043/0001564590-20-025043-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020039316/0001564590-20-039316-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459020039319/0001564590-20-039319-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020045922/0001564590-20-045922-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000162363220000229/0001623632-20-000229-index.htm
2015-09-16DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000165308715000001/0001653087-15-000001-index.htm
2019-02-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1653087/999999999519000107/9999999995-19-000107-index.htm
2020-01-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1653087/999999999520000190/9999999995-20-000190-index.htm
2019-02-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1653087/999999999719000119/9999999997-19-000119-index.htm

Alector, Inc (ALEC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alector, Inc (ALEC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1281%
Institutional Ownership: 7894%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell38,808.0026.001,009,008.000.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2019-02-11CARL L GORDONDirectorBuy157,939.0019.003,000,841.0010,434,976.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy157,939.0019.003,000,841.0010,434,976.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-02-07Calvin YuVice President, FinanceSell24,033.0035.02841,635.66110,686.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-06-03Calvin YuVice President, FinanceSell300.0032.029,606.00110,686.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-06-03Calvin YuVice President, FinanceSell1,043.0031.0432,374.72110,986.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-02-06Calvin YuVice President, FinanceSell2,621.0035.0091,735.00124,494.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-04Calvin YuVice President, FinanceSell63,541.0030.041,908,771.64125,294.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-02-06Calvin YuVice President, FinanceBuy1,096.008.168,943.36126,390.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-06Calvin YuVice President, FinanceBuy725.0010.147,351.50127,115.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-07Calvin YuVice President, FinanceBuy2,825.008.1623,052.00127,319.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-06-23Polaris Venture Management Co. VI, L.L.C.10% Share HolderSell4,377.0031.54138,062.8412,853,817.00https://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm
2020-06-23TERRANCE MCGUIREDirectorSell4,377.0031.54138,062.8412,853,817.00https://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2020-02-07Calvin YuVice President, FinanceBuy7,400.0010.1475,036.00134,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2019-12-03Calvin YuVice President, FinanceSell1,315.0018.3124,077.65175,294.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm
2020-02-04Calvin YuVice President, FinanceBuy13,541.008.16110,494.56188,835.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-04-16ORBIMED ADVISORS LLC10% Share HolderSell15,086.0023.53354,973.581,906,718.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-04-14ORBIMED ADVISORS LLC10% Share HolderSell5,636.0023.52132,558.721,921,804.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-04-09ORBIMED ADVISORS LLC10% Share HolderSell69,893.0023.791,662,754.471,927,440.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-08ORBIMED ADVISORS LLC10% Share HolderSell20,041.0023.65473,969.651,997,333.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-07ORBIMED ADVISORS LLC10% Share HolderSell2,224.0023.1051,374.402,017,374.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-03-31ORBIMED ADVISORS LLC10% Share HolderSell60,645.0024.501,485,802.502,019,598.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2019-02-11CARL L GORDONDirectorBuy203,200.0019.003,860,800.00203,200.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy203,200.0019.003,860,800.00203,200.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-03-25ORBIMED ADVISORS LLC10% Share HolderSell13,684.0024.66337,447.442,080,243.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-24ORBIMED ADVISORS LLC10% Share HolderSell16,409.0024.45401,200.052,093,927.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-23ORBIMED ADVISORS LLC10% Share HolderSell3,541.0026.0592,243.052,110,336.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell445,086.0026.0011,572,236.002,113,877.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-07-15Robert PaulChief Medical OfficerSell378.0023.588,913.24213,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-07-15Robert PaulChief Medical OfficerSell9,622.0022.94220,728.68214,097.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-06-15Robert PaulChief Medical OfficerSell3,909.0029.90116,879.10223,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-06-15Robert PaulChief Medical OfficerSell6,091.0029.43179,258.13227,628.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-05-15Robert PaulChief Medical OfficerSell2,104.0027.7858,449.12233,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-05-15Robert PaulChief Medical OfficerSell5,996.0027.00161,892.00235,823.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-05-15Robert PaulChief Medical OfficerSell1,900.0026.1549,685.00241,819.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-04-15Robert PaulChief Medical OfficerSell10,000.0022.27222,700.00243,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm
2019-02-11CARL L GORDONDirectorBuy50,561.0019.00960,659.002,455,853.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy50,561.0019.00960,659.002,455,853.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-03-13Robert PaulChief Medical OfficerSell176.0024.464,304.96253,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-13Robert PaulChief Medical OfficerSell5,459.0023.49128,231.91253,895.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell91,818.0019.501,790,451.002,558,963.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2020-03-13Robert PaulChief Medical OfficerSell2,884.0022.4764,803.48259,354.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-13Robert PaulChief Medical OfficerSell1,481.0021.5731,945.17262,238.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-02-14Robert PaulChief Medical OfficerSell7,000.0029.74208,180.00263,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell2,325.0018.6043,245.002,650,781.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell15,476.0019.59303,174.842,653,106.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell20,350.0019.82403,337.002,668,582.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell73,879.0019.661,452,461.142,688,932.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-14Robert PaulChief Medical OfficerSell3,000.0029.0787,210.00270,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2020-01-15Robert PaulChief Medical OfficerSell10,000.0018.67186,700.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm
2020-01-23Robert PaulChief Medical OfficerSell599.0025.2215,106.78273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-30Robert PaulChief Medical OfficerSell8,000.0028.00224,000.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-05Robert PaulChief Medical OfficerSell10,000.0032.10321,000.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2020-01-23Robert PaulChief Medical OfficerSell5,401.0024.22130,812.22274,318.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell205,793.0018.523,811,286.362,762,811.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2020-01-23Robert PaulChief Medical OfficerBuy6,000.008.1648,960.00279,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-30Robert PaulChief Medical OfficerBuy8,000.008.1665,280.00281,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-05Robert PaulChief Medical OfficerBuy10,000.008.1681,600.00283,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2019-12-13Robert PaulChief Medical OfficerSell10,000.0020.03200,300.00283,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm
2019-11-15Robert PaulChief Medical OfficerSell10,000.0015.93159,300.00293,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm
2019-08-07ORBIMED ADVISORS LLC10% Share HolderSell157,636.0017.902,821,684.402,968,604.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-10-15Robert PaulChief Medical OfficerSell10,000.0014.68146,800.00301,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm
2019-09-16Robert PaulChief Medical OfficerSell10,000.0019.08190,800.00311,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm
2019-09-20Robert PaulChief Medical OfficerSell4,000.0020.0080,000.00311,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-09-20Robert PaulChief Medical OfficerBuy4,000.008.1632,640.00315,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-08-20Robert PaulChief Medical OfficerSell916.0016.0014,656.00321,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-19Robert PaulChief Medical OfficerSell1,084.0016.0017,344.00322,635.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-15Robert PaulChief Medical OfficerSell10,000.0014.19141,900.00323,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell1,392.0019.5027,144.0038,808.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell1,200.0018.6022,320.0040,200.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell8,000.0019.59156,720.0041,400.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-03David M. WehnerDirectorBuy20,000.0025.00500,000.0044,621.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm
2020-05-15Robert KingChief Development OfficerSell3,003.0027.7883,423.34477,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-15Robert KingChief Development OfficerSell8,632.0027.02233,236.64480,320.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-15Robert KingChief Development OfficerSell3,365.0026.2488,297.60488,952.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-02-14Robert KingChief Development OfficerSell10,332.0029.77307,583.64492,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell10,400.0019.82206,128.0049,400.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-14Robert KingChief Development OfficerSell4,668.0029.09135,792.12502,649.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2020-01-22Robert KingChief Development OfficerSell3.0022.0166.03507,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2020-01-21Robert KingChief Development OfficerSell14,997.0022.01330,083.97507,320.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2019-11-15Robert KingChief Development OfficerSell7,500.0015.92119,400.00522,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm
2019-08-19Robert KingChief Development OfficerSell7,500.0015.00112,500.00529,817.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm
2020-02-07Sabah OneyChief Business OfficerSell19,900.0035.03697,097.00573,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm
2020-02-06Sabah OneyChief Business OfficerSell100.0035.003,500.00593,818.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2019-09-20Sabah OneyChief Business OfficerSell400.0020.008,000.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-12-05Sabah OneyChief Business OfficerSell1,500.0020.0030,000.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-06Sabah OneyChief Business OfficerSell5,156.0020.02103,223.12593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-09Sabah OneyChief Business OfficerSell2,300.0020.0746,161.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-10Sabah OneyChief Business OfficerSell500.0020.0110,005.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-12Sabah OneyChief Business OfficerSell6,810.0020.13137,068.96593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2020-01-23Sabah OneyChief Business OfficerSell2,200.0025.2155,462.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-01-27Sabah OneyChief Business OfficerSell14,467.0025.05362,398.35593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-02-04Sabah OneyChief Business OfficerSell16,667.0030.00500,010.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2019-09-20Sabah OneyChief Business OfficerBuy400.008.163,264.00594,318.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-12-10Sabah OneyChief Business OfficerBuy500.008.164,080.00594,418.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-05Sabah OneyChief Business OfficerBuy1,500.008.1612,240.00595,418.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2020-04-16ORBIMED ADVISORS LLC10% Share HolderSell47,097.0023.531,108,192.415,955,674.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-01-23Sabah OneyChief Business OfficerBuy2,200.008.1617,952.00596,118.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2019-12-09Sabah OneyChief Business OfficerBuy2,300.008.1618,768.00596,218.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell37,900.0019.66745,114.0059,800.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-06Sabah OneyChief Business OfficerBuy5,156.008.1642,072.96599,074.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2020-04-14ORBIMED ADVISORS LLC10% Share HolderSell17,595.0023.52413,834.406,002,771.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2019-12-12Sabah OneyChief Business OfficerBuy6,810.008.1655,569.60600,728.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2020-04-09ORBIMED ADVISORS LLC10% Share HolderSell218,208.0023.795,191,168.326,020,366.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-01-27Sabah OneyChief Business OfficerBuy14,467.008.16118,050.72608,385.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-02-04Sabah OneyChief Business OfficerBuy16,667.008.16136,002.72610,585.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2020-04-08ORBIMED ADVISORS LLC10% Share HolderSell62,573.0023.651,479,851.456,238,574.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-07ORBIMED ADVISORS LLC10% Share HolderSell6,946.0023.10160,452.606,301,147.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-03-31ORBIMED ADVISORS LLC10% Share HolderSell189,355.0024.504,639,197.506,308,093.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2020-03-25ORBIMED ADVISORS LLC10% Share HolderSell42,727.0024.661,053,647.826,497,448.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-24ORBIMED ADVISORS LLC10% Share HolderSell51,235.0024.451,252,695.756,540,175.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-23ORBIMED ADVISORS LLC10% Share HolderSell11,057.0026.05288,034.856,591,410.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell1,390,309.0026.0036,148,034.006,602,467.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell286,787.0019.505,592,346.507,992,776.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell7,275.0018.60135,315.008,279,563.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell48,324.0019.59946,667.168,286,838.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell63,535.0019.821,259,263.708,335,162.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell230,721.0019.664,535,974.868,398,697.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell642,807.0018.5211,904,785.648,629,418.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2019-08-07ORBIMED ADVISORS LLC10% Share HolderSell492,364.0017.908,813,315.609,272,225.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell105,500.0018.521,953,860.0097,700.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2020-02-04RICHARD H SCHELLERDirectorSell10,000.0029.67296,700.009,981.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm